bf/NASDAQ:VIVO_icon.png

NASDAQ:VIVO

Meridian Bioscience, Inc.

  • Stock

USD

Last Close

33.97

30/01 21:00

Market Cap

1.49B

Beta: -

Volume Today

5.63M

Avg: 686.61K

PE Ratio

−551.87

PFCF: 42.66

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '13
Sep '14
Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
average inventory
33.26M
-
35.16M
5.73%
35.66M
1.40%
40.44M
13.41%
43.27M
7.02%
41.74M
3.54%
40.80M
2.25%
50.44M
23.61%
69.05M
36.90%
72.33M
4.74%
average payables
5.69M
-
5.28M
7.27%
5.81M
9.98%
7.14M
22.92%
7.67M
7.52%
6.99M
8.91%
6.75M
3.44%
9.60M
42.30%
11.84M
23.24%
14.73M
24.46%
average receivables
25.18M
-
24.71M
1.89%
24.74M
0.14%
26.68M
7.82%
28.10M
5.35%
30.72M
9.31%
33.97M
10.58%
37.06M
9.09%
46.04M
24.23%
50.40M
9.47%
book value per share
3.76
-
3.88
3.29%
3.98
2.50%
3.96
0.48%
4.02
1.44%
4.14
3.10%
4.49
8.23%
5.78
28.81%
7.59
31.34%
8.51
12.11%
capex per share
-0.08
-
-0.17
112.49%
-0.11
32.30%
-0.10
16.66%
-0.11
11.09%
-0.10
6.26%
-0.09
10.14%
-0.08
13.69%
-0.42
449.89%
-0.20
52.95%
capex to depreciation
-0.58
-
-1.26
116.01%
-0.91
27.48%
-0.60
33.82%
-0.55
8.93%
-0.53
3.65%
-0.38
28.12%
-0.24
36.19%
-1.20
392.66%
-0.52
56.44%
capex to operating cash flow
-0.07
-
-0.18
148.15%
-0.11
39.19%
-0.11
3.34%
-0.11
0.42%
-0.12
11.81%
-0.11
12.26%
-0.07
35.11%
-0.27
298.27%
-0.10
61.81%
capex to revenue
-0.02
-
-0.04
113.51%
-0.02
34.06%
-0.02
16.49%
-0.02
8.96%
-0.02
11.59%
-0.02
3.97%
-0.01
31.15%
-0.06
342.93%
-0.03
55.09%
cash per share
1.07
-
1.04
3.33%
1.20
15.52%
1.12
6.29%
1.35
20.34%
1.41
4.38%
1.47
3.80%
1.25
14.80%
1.15
7.86%
1.88
63.66%
days of inventory on hand
187.97
-
180.97
3.72%
179.21
0.97%
240.81
34.37%
199.44
17.18%
184.42
7.53%
174.87
5.18%
229.54
31.26%
240.24
4.66%
171.10
28.78%
days payables outstanding
30.17
-
25.32
16.09%
33.25
31.34%
40.76
22.58%
37.10
8.98%
27.49
25.90%
31.95
16.21%
44.84
40.36%
36.58
18.42%
44.81
22.49%
days sales outstanding
50.65
-
44.91
11.34%
49.18
9.53%
50.45
2.57%
52.91
4.89%
55.26
4.44%
64.66
17.00%
55.41
14.29%
61.51
10.99%
51.77
15.83%
debt to assets
0.12
-
0.09
26.81%
0.09
5.70%
0.34
256.83%
0.32
5.27%
0.30
5.88%
0.41
36.77%
0.39
5.88%
0.27
30.59%
0.21
23.99%
debt to equity
0.14
-
0.10
29.46%
0.10
6.29%
0.51
388.51%
0.47
7.77%
0.43
8.43%
0.70
62.67%
0.64
9.63%
0.37
41.90%
0.26
30.18%
dividend yield
0.03
-
0.04
38.81%
0.05
4.81%
0.04
11.32%
0.04
3.13%
0.03
15.87%
0.03
22.38%
earnings yield
0.04
-
0.05
21.36%
0.05
5.31%
0.04
20.28%
0.04
10.15%
0.04
6.69%
0.06
58.30%
0.06
5.17%
0.09
35.17%
0.03
63.72%
enterprise value
929.93M
-
690.29M
25.77%
662.40M
4.04%
821.51M
24.02%
600.86M
26.86%
615.98M
2.52%
417.43M
32.23%
744.78M
78.42%
848.45M
13.92%
1.31B
54.81%
enterprise value over ebitda
14.76
-
11.97
18.93%
10.99
8.20%
14.12
28.53%
13.01
7.89%
15.47
18.90%
9.60
37.91%
9.87
2.73%
7.88
20.08%
18.24
131.33%
ev to operating cash flow
20.93
-
18.04
13.79%
15.47
14.23%
22.07
42.63%
14.53
34.17%
17.71
21.89%
11.65
34.22%
15.52
33.25%
12.69
18.26%
15.95
25.68%
ev to sales
4.93
-
3.66
25.83%
3.40
7.00%
4.19
23.23%
2.99
28.57%
2.88
3.63%
2.08
28.00%
2.94
41.39%
2.67
9.10%
3.94
47.78%
free cash flow per share
1.00
-
0.75
24.47%
0.91
21.11%
0.79
13.41%
0.87
10.58%
0.72
17.36%
0.75
4.14%
1.04
38.54%
1.12
7.66%
1.70
51.89%
free cash flow yield
0.04
-
0.04
0.90%
0.05
25.29%
0.04
23.24%
0.06
49.16%
0.05
20.05%
0.08
62.19%
0.06
22.57%
0.06
4.99%
0.05
7.32%
graham net net
1.45
-
1.50
3.92%
1.68
12.04%
0.11
93.31%
0.46
309.60%
0.69
48.84%
-0.60
187.61%
-1.04
73.08%
0.16
115.43%
1.29
702.39%
graham number
8.84
-
8.56
3.13%
8.74
2.15%
8.27
5.40%
6.80
17.80%
7.25
6.63%
7.60
4.89%
11.84
55.69%
16.79
41.83%
13.71
18.35%
income quality
1.17
-
1.10
5.74%
1.20
9.37%
1.15
4.12%
1.92
66.10%
1.46
23.97%
1.47
0.76%
1.04
29.32%
0.94
9.85%
1.94
107.15%
intangibles to total assets
0.18
-
0.18
0.63%
0.15
11.95%
0.36
136.35%
0.33
10.39%
0.31
5.36%
0.46
48.49%
0.49
6.05%
0.44
9.23%
0.41
6.98%
interest coverage
57.28
-
22.77
60.25%
20.78
8.73%
16.81
19.09%
23.30
38.59%
49.54
112.62%
45.75
7.66%
interest debt per share
1.41
-
1.33
5.41%
1.22
8.45%
1.83
49.55%
1.71
6.44%
1.57
8.30%
0.74
52.59%
inventory turnover
1.94
-
2.02
3.87%
2.04
0.98%
1.52
25.58%
1.83
20.74%
1.98
8.14%
2.09
5.46%
1.59
23.81%
1.52
4.45%
2.13
40.41%
invested capital
0.35
-
0.32
8.08%
0.29
11.23%
0.40
38.80%
0.29
28.18%
0.20
29.58%
0.08
58.11%
market cap
974.21M
-
733.34M
24.72%
712.37M
2.86%
810.37M
13.76%
603.29M
25.55%
625.56M
3.69%
404.00M
35.42%
727.68M
80.12%
832.30M
14.38%
1.36B
63.88%
net current asset value
92.39M
-
96.85M
4.83%
105.44M
8.88%
41.44M
60.70%
53.68M
29.54%
63.09M
17.53%
10.25M
83.75%
4.56M
55.53%
71.39M
1,466.19%
115.56M
61.88%
net debt to ebitda
-0.70
-
-0.75
6.17%
-0.83
11.06%
0.19
123.09%
-0.05
127.43%
-0.24
358.34%
0.31
228.37%
0.23
26.68%
0.15
33.74%
-0.70
567.19%
net income per share
0.92
-
0.84
9.15%
0.85
1.79%
0.77
10.07%
0.51
33.40%
0.56
10.27%
0.57
1.64%
1.08
88.17%
1.65
53.16%
0.98
40.54%
operating cash flow per share
1.08
-
0.92
14.37%
1.03
11.34%
0.89
13.78%
0.98
10.63%
0.82
16.16%
0.84
2.42%
1.12
33.01%
1.55
38.07%
1.90
23.18%
payables turnover
12.10
-
14.42
19.18%
10.98
23.86%
8.95
18.42%
9.84
9.87%
13.28
34.95%
11.42
13.95%
8.14
28.75%
9.98
22.59%
8.15
18.36%
receivables turnover
7.21
-
8.13
12.79%
7.42
8.70%
7.23
2.51%
6.90
4.66%
6.60
4.25%
5.65
14.53%
6.59
16.68%
5.93
9.90%
7.05
18.80%
research and ddevelopement to revenue
0.06
-
0.07
16.27%
0.06
2.67%
0.07
8.90%
0.08
10.85%
0.08
1.14%
0.09
13.04%
0.09
4.77%
0.08
19.59%
0.07
2.85%
return on tangible assets
0.26
-
0.24
8.87%
0.23
3.70%
0.20
12.14%
0.13
36.36%
0.14
7.14%
0.14
0.86%
0.22
60.37%
0.28
28.10%
0.16
45.28%
revenue per share
4.58
-
4.56
0.48%
4.68
2.67%
4.67
0.20%
4.76
1.96%
5.05
6.03%
4.72
6.42%
5.92
25.36%
7.35
24.15%
7.70
4.76%
roe
0.25
-
0.22
12.04%
0.21
0.69%
0.19
9.64%
0.13
34.34%
0.14
6.95%
0.13
6.09%
0.19
46.08%
0.22
16.62%
0.12
46.96%
roic
0.46
-
0.41
11.58%
0.47
15.98%
0.22
53.72%
0.17
20.80%
0.20
14.16%
0.13
33.85%
0.17
27.77%
0.22
30.04%
0.15
30.62%
sales general and administrative to revenue
0.16
-
0.15
10.33%
0.14
2.28%
0.16
9.97%
0.16
5.58%
0.16
1.88%
0.17
6.55%
0.18
6.37%
0.16
10.03%
0.17
4.22%
shareholders equity per share
3.76
-
3.88
3.29%
3.98
2.50%
3.96
0.48%
4.02
1.44%
4.14
3.10%
4.49
8.23%
5.78
28.81%
7.59
31.34%
8.51
12.11%
stock based compensation to revenue
0.01
-
0.02
42.06%
0.02
9.43%
0.01
12.98%
0.02
13.43%
0.02
5.41%
0.02
1.53%
0.01
7.33%
0.01
12.77%
0.02
58.49%
tangible asset value
123.87M
-
130.02M
4.96%
137.59M
5.82%
74.64M
45.76%
87.95M
17.85%
97.67M
11.04%
41.48M
57.53%
50.25M
21.12%
129.48M
157.70%
177.63M
37.18%
tangible book value per share
3.00
-
3.14
4.38%
3.30
5.30%
1.78
46.21%
2.08
17.35%
2.31
10.68%
0.97
57.77%
1.17
20.32%
2.99
155.29%
4.11
37.18%
working capital
92.39M
-
99.01M
7.17%
107.60M
8.67%
104.22M
3.14%
110.99M
6.49%
114.88M
3.51%
123.85M
7.81%
109.67M
11.45%
145.65M
32.81%
152.65M
4.80%

All numbers in USD (except ratios and percentages)